Ayutara ...

SEC Filings

Regulatory filings and disclosures.

10-Q Oct 30, 2025
Q3 2025 Quarterly Report
Financial statements, clinical trial progress, and risk updates for the quarter ended September 30, 2025.
PDF XBRL EDGAR
8-K Oct 15, 2025
New Credit Facility Agreement
$150M revolving credit line with JPMorgan to fund Phase III trials and manufacturing.
PDF EDGAR
DEF 14A Sep 20, 2025
2025 Proxy Statement
Annual meeting notice, board nominees, executive compensation, and governance policies.
PDF EDGAR
10-Q Jul 31, 2025
Q2 2025 Quarterly Report
Revenue growth of 42%, pipeline updates, and operational milestones.
PDF XBRL EDGAR
S-3 May 05, 2025
Shelf Registration
Registration of up to $500M in securities for future capital raises.
PDF EDGAR
Form 4 – Insider Transaction
Filed: Nov 04, 2025
PDF XBRL
Certification of CEO/CFO
Filed: Oct 30, 2025
PDF
Earnings Press Release
Filed: Oct 30, 2025
PDF
Form 10-K (2024)
Filed: Feb 28, 2025
PDF XBRL
Annual Reports (10-K)
Comprehensive audited financials, business overview, and risk factors.
Quarterly Reports (10-Q)
Unaudited financial results and management's discussion & analysis.
Current Reports (8-K)
Material events including earnings, agreements, and leadership changes.
Proxy Statements (DEF 14A)
Shareholder voting, director elections, and executive compensation details.
Filing Calendar
Upcoming filing dates and earnings schedule.
IR Contact
Reach out for filing questions or clarifications.
Compliance Portal
Secure access to insider filings and disclosures.

Never Miss a Filing

Get instant email alerts for new SEC submissions, earnings, and material events.